• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球 DNA 甲基化分析揭示 IDH 突变型星形细胞瘤中的染色体不稳定性。

Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas.

机构信息

Eugene McDermott Center for Human Growth & Development, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

Department of Neurosurgery, University of Pittsburgh School of Medicine, 200 Lothrop St, Pittsburgh, PA, 15213, USA.

出版信息

Acta Neuropathol Commun. 2022 Mar 9;10(1):32. doi: 10.1186/s40478-022-01339-2.

DOI:10.1186/s40478-022-01339-2
PMID:35264242
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8908645/
Abstract

Diffusely infiltrating gliomas are among the most common central nervous system tumors in adults. Over the past decade, the subcategorization of these tumors has changed to include both traditional histologic features and more recently identified molecular factors. However, one molecular feature that has yet to be integrated is the presence/absence of chromosomal instability (CIN). Herein, we use global methylation profiling to evaluate a reference cohort of IDH-mutant astrocytomas with and without prior evidence of CIN (n = 42), and apply the resulting methylation-based characteristics to a larger test cohort of publicly-available IDH-mutant astrocytomas (n = 245). We demonstrate that IDH-mutant astrocytomas with evidence of CIN cluster separately from their chromosomally-stable counterparts. CIN cases were associated with higher initial histologic grade, altered expression patterns of genes related to CIN in other cancers, elevated initial total copy number burden, and significantly worse progression-free and overall survival. In addition, in a grade-for-grade analysis, patients with CIN-positive WHO grade 2 and 3 tumors had significantly worse survival. These results suggest that global methylation profiling can be used to discriminate between chromosomally stable and unstable IDH-mutant astrocytomas, and may therefore provide a reliable and cost-effective method for identifying gliomas with chromosomal instability and resultant poor clinical outcome.

摘要

弥漫性浸润性神经胶质瘤是成人中枢神经系统最常见的肿瘤之一。在过去的十年中,这些肿瘤的分类已经改变,包括传统的组织学特征和最近确定的分子因素。然而,尚未整合的一个分子特征是染色体不稳定性(CIN)的存在/缺失。在此,我们使用全局甲基化分析来评估一组具有和不具有先前 CIN 证据的 IDH 突变星形细胞瘤参考队列(n = 42),并将由此产生的基于甲基化的特征应用于更大的公开可用 IDH 突变星形细胞瘤测试队列(n = 245)。我们证明,具有 CIN 证据的 IDH 突变星形细胞瘤与它们的染色体稳定对应物分离。CIN 病例与较高的初始组织学分级、其他癌症中与 CIN 相关的基因表达模式改变、初始总拷贝数负担升高以及无进展生存期和总生存期明显更差相关。此外,在分级分析中,CIN 阳性的 WHO 分级 2 和 3 肿瘤患者的生存率明显更差。这些结果表明,全局甲基化分析可用于区分染色体稳定和不稳定的 IDH 突变星形细胞瘤,因此可能为识别具有染色体不稳定性和不良临床结局的神经胶质瘤提供一种可靠且具有成本效益的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/578929cbb605/40478_2022_1339_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/f10524797e32/40478_2022_1339_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/346d31c527b7/40478_2022_1339_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/beb3cc68487e/40478_2022_1339_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/578929cbb605/40478_2022_1339_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/f10524797e32/40478_2022_1339_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/346d31c527b7/40478_2022_1339_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/beb3cc68487e/40478_2022_1339_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/8908645/578929cbb605/40478_2022_1339_Fig4_HTML.jpg

相似文献

1
Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas.全球 DNA 甲基化分析揭示 IDH 突变型星形细胞瘤中的染色体不稳定性。
Acta Neuropathol Commun. 2022 Mar 9;10(1):32. doi: 10.1186/s40478-022-01339-2.
2
Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas.分子特征与染色体不稳定性与 IDH 突变型和 IDH 野生型星形细胞瘤的拷贝数变异模式和患者预后相关。
J Neuropathol Exp Neurol. 2021 Mar 22;80(4):354-365. doi: 10.1093/jnen/nlab008.
3
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma.遗传和表观遗传不稳定性是 IDH 突变型星形细胞瘤进展和侵袭性行为的潜在驱动因素。
Acta Neuropathol. 2024 Jul 16;148(1):5. doi: 10.1007/s00401-024-02761-7.
4
Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classification.基于 DNA 甲基化分类的 IDH 突变型星形细胞瘤预后的细化。
Brain Pathol. 2024 Sep;34(5):e13233. doi: 10.1111/bpa.13233. Epub 2024 Jan 2.
5
Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.异柠檬酸脱氢酶(IDH)突变型星形细胞瘤亚组中快速进展为胶质母细胞瘤:全基因组分析
J Neurooncol. 2017 May;133(1):183-192. doi: 10.1007/s11060-017-2431-y. Epub 2017 Apr 18.
6
Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas.快速进展型 IDH 突变星形细胞瘤的遗传和表观遗传特征。
J Neuropathol Exp Neurol. 2018 Jul 1;77(7):542-548. doi: 10.1093/jnen/nly026.
7
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma.CDKN2A/B半合子缺失在异柠檬酸脱氢酶(IDH)突变型胶质瘤中的预后影响
Neuro Oncol. 2025 Mar 7;27(3):743-754. doi: 10.1093/neuonc/noae238.
8
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design.一项关于异柠檬酸脱氢酶(IDH)突变型4级胶质瘤的多中心临床分析:对预后和临床试验设计的意义
J Neurooncol. 2025 Jan;171(2):373-381. doi: 10.1007/s11060-024-04852-7. Epub 2024 Oct 21.
9
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.原发性错配修复缺陷伴 IDH 突变型星形细胞瘤(PMMRDIA)是一种预后不良的独特类型。
Acta Neuropathol. 2021 Jan;141(1):85-100. doi: 10.1007/s00401-020-02243-6. Epub 2020 Nov 20.
10
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas.成人型 IDH 突变型胶质瘤的纵向 DNA 甲基化分析。
Acta Neuropathol Commun. 2023 Feb 4;11(1):23. doi: 10.1186/s40478-023-01520-1.

引用本文的文献

1
Therapy enhancing chromosome instability may be advantageous for gliomas.增强染色体不稳定性的疗法可能对神经胶质瘤有利。
NAR Cancer. 2025 Feb 13;7(1):zcaf003. doi: 10.1093/narcan/zcaf003. eCollection 2025 Mar.
2
The molecular history of IDH-mutant astrocytomas without adjuvant treatment.未接受辅助治疗的异柠檬酸脱氢酶(IDH)突变型星形细胞瘤的分子史。
Brain Pathol. 2025 Mar;35(2):e13300. doi: 10.1111/bpa.13300. Epub 2024 Oct 30.
3
Chromosomal instability: a key driver in glioma pathogenesis and progression.染色体不稳定性:胶质母细胞瘤发病机制和进展的关键驱动因素。

本文引用的文献

1
DNA Methylation Profiling: An Emerging Paradigm for Cancer Diagnosis.DNA 甲基化分析:癌症诊断的新兴范例。
Annu Rev Pathol. 2022 Jan 24;17:295-321. doi: 10.1146/annurev-pathol-042220-022304. Epub 2021 Nov 4.
2
DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology.DNA 甲基化分析作为神经肿瘤学中发现和精准诊断的模型。
Neuro Oncol. 2021 Nov 2;23(23 Suppl 5):S16-S29. doi: 10.1093/neuonc/noab143.
3
Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
Eur J Med Res. 2024 Sep 4;29(1):451. doi: 10.1186/s40001-024-02043-8.
4
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma.遗传和表观遗传不稳定性是 IDH 突变型星形细胞瘤进展和侵袭性行为的潜在驱动因素。
Acta Neuropathol. 2024 Jul 16;148(1):5. doi: 10.1007/s00401-024-02761-7.
5
Chromothripsis is rare in IDH-mutant gliomas compared to IDH-wild-type glioblastomas whereas whole-genome duplication is equally frequent in both tumor types.与异柠檬酸脱氢酶(IDH)野生型胶质母细胞瘤相比,染色体碎裂在IDH突变型神经胶质瘤中较为罕见,而全基因组复制在这两种肿瘤类型中出现的频率相当。
Neurooncol Adv. 2024 Apr 18;6(1):vdae059. doi: 10.1093/noajnl/vdae059. eCollection 2024 Jan-Dec.
6
Investigating chromosomal instability in long-term survivors with glioblastoma and grade 4 astrocytoma.研究胶质母细胞瘤和4级星形细胞瘤长期幸存者的染色体不稳定性。
Front Oncol. 2024 Jan 8;13:1218297. doi: 10.3389/fonc.2023.1218297. eCollection 2023.
7
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma.异柠檬酸脱氢酶(IDH)突变型星形细胞瘤和IDH野生型胶质母细胞瘤中的错配修复蛋白突变
Neurooncol Adv. 2023 Jul 12;5(1):vdad085. doi: 10.1093/noajnl/vdad085. eCollection 2023 Jan-Dec.
8
CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma.在异柠檬酸脱氢酶(IDH)突变型星形细胞瘤中,CDKN2A突变与纯合缺失具有同等的预后意义。
J Neuropathol Exp Neurol. 2023 Sep 20;82(10):845-852. doi: 10.1093/jnen/nlad063.
9
The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomas.2-4级星形细胞瘤中亚克隆性异柠檬酸脱氢酶1(IDH1)突变的预后影响
Neurooncol Adv. 2023 May 29;5(1):vdad069. doi: 10.1093/noajnl/vdad069. eCollection 2023 Jan-Dec.
10
Chromosomal instability in adult-type diffuse gliomas.成人型弥漫性神经胶质瘤中的染色体不稳定性。
Acta Neuropathol Commun. 2022 Aug 17;10(1):115. doi: 10.1186/s40478-022-01420-w.
基于 DNA 甲基化图谱分析的 IDH 突变型胶质母细胞瘤的空间进展和分子异质性。
Acta Neuropathol Commun. 2021 Jun 30;9(1):120. doi: 10.1186/s40478-021-01221-7.
4
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
5
Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas.分子特征与染色体不稳定性与 IDH 突变型和 IDH 野生型星形细胞瘤的拷贝数变异模式和患者预后相关。
J Neuropathol Exp Neurol. 2021 Mar 22;80(4):354-365. doi: 10.1093/jnen/nlab008.
6
Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts.IDH 野生型胶质母细胞瘤队列中长生存的分子相关性。
J Neuropathol Exp Neurol. 2020 Aug 1;79(8):843-854. doi: 10.1093/jnen/nlaa059.
7
Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas.超越异柠檬酸脱氢酶(IDH)突变:成人弥漫性胶质瘤中新兴的分子诊断和预后特征
Cancers (Basel). 2020 Jul 6;12(7):1817. doi: 10.3390/cancers12071817.
8
Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.探索 DNA 甲基化在多形性黄色星形细胞瘤中的预后价值并分析肿瘤微环境。
J Neuropathol Exp Neurol. 2020 Aug 1;79(8):880-890. doi: 10.1093/jnen/nlaa051.
9
Chromosome Instability; Implications in Cancer Development, Progression, and Clinical Outcomes.染色体不稳定性;对癌症发生、发展及临床结局的影响
Cancers (Basel). 2020 Mar 29;12(4):824. doi: 10.3390/cancers12040824.
10
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.cIMPACT-NOW更新5:IDH突变型星形细胞瘤的推荐分级标准和术语
Acta Neuropathol. 2020 Mar;139(3):603-608. doi: 10.1007/s00401-020-02127-9. Epub 2020 Jan 29.